A training-testing approach to the molecular classification of resected non-small cell lung cancer.

PURPOSE RNA expression patterns associated with non-small cell lung cancer subclassification have been reported, but there are substantial differences in the key genes and clinical features of these subsets casting doubt on their biological significance. EXPERIMENTAL DESIGN In this study, we used a training-testing approach to test the reliability of cDNA microarray-based classifications of resected human non-small cell lung cancers (NSCLCs) analyzed by cDNA microarray. RESULTS Groups of genes were identified that were able to differentiate primary tumors from normal lung and lung metastases, as well as identify known histological subgroups of NSCLCs. Groups of genes were identified to discriminate sample clusters. A blinded confirmatory set of tumors was correctly classified by using these patterns. Some histologically diagnosed large cell tumors were clearly classified by expression profile analysis as being either adenocarcinoma or squamous cell carcinoma, indicating that this group of tumors may not be genetically homogeneous. High alpha-actinin-4 expression was identified as highly correlated with poor prognosis. CONCLUSIONS These results demonstrate that gene expression profiling can identify molecular classes of resected NSCLCs that correctly classifies a blinded test cohort, and correlates with and supplements standard histological evaluation.

[1]  P. Bunn,et al.  New anti‐lung‐cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[2]  U. Alon,et al.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Brian Everitt,et al.  Cluster analysis , 1974 .

[5]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[6]  David E. Misek,et al.  Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.

[7]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[8]  J. Schiller,et al.  Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer , 2001, Oncology.

[9]  D. Lockhart,et al.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  The World Health Organization. Histological typing of lung tumours. , 1982, Neoplasma.

[11]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[12]  Werner Dubitzky,et al.  A Practical Approach to Microarray Data Analysis , 2003, Springer US.

[13]  G. Blobel,et al.  Cytokeratins in normal lung and lung carcinomas , 1984, Virchows Archiv. B, Cell pathology including molecular pathology.

[14]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Jonathan Knight,et al.  When the chips are down , 2001, Nature.

[16]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Lombardo,et al.  Pattern of mucin gene expression in normal and neoplastic lung tissues. , 1996, Anticancer research.

[18]  Yu Shyr,et al.  Weighted Flexible Compound Covariate Method for Classifying Microarray Data , 2003 .

[19]  Hitoshi Tsuda,et al.  Actinin-4, a Novel Actin-bundling Protein Associated with Cell Motility and Cancer Invasion , 1998, The Journal of cell biology.

[20]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. Dougherty,et al.  Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.

[22]  Nir Friedman,et al.  Scoring Genes for Relevance , 2000 .

[23]  J. Tukey.  Tightening the clinical trial. , 1993, Controlled clinical trials.

[24]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[25]  N. Lee,et al.  A concise guide to cDNA microarray analysis. , 2000, BioTechniques.

[26]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.